Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
7.75
-0.36 (-4.44%)
At close: Aug 22, 2025, 4:00 PM
7.77
+0.02 (0.26%)
After-hours: Aug 22, 2025, 7:06 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Antibody-drug Conjugates
40.50M
Log In
Log In
Log In
Log In
Upgrade
Antibody-drug Conjugates Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
40.50M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.88%
Log In
Log In
Log In
Log In
Upgrade